Surface-Active Fungicidal d -Peptide Inhibitors of the Plasma Membrane Proton Pump That Block Azole Resistance
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
A 1.8-million-member d -octapeptide combinatorial library was constructed in which each member comprised a diversity-containing N-terminal pentapeptide and a C-terminal amidated triarginine motif. The C-terminal motif concentrated the library members at the fungal cell surface. A primary screen for inhibitors of Saccharomyces cerevisiae and Candida albicans growth, together with an in vitro secondary screen with the S. cerevisiae plasma membrane ATPase (Pma1p) as a target, identified the antifungal d -octapeptide BM0 ( d -NH 2 -RFWWFRRR-CONH 2 ). Optimization of BM0 led to the construction of BM2 ( d -NH 2 -RRRFWWFRRR-CONH 2 ), which had broad-spectrum fungicidal activity against S. cerevisiae , Candida species, and Cryptococcus neoformans ; bound strongly to the surfaces of fungal cells; inhibited the physiological activity of Pma1p; and appeared to target Pma1p, with 50% inhibitory concentrations in the range of 0.5 to 2.5 μM. At sub-MICs (<5 μM), BM2 chemosensitized to fluconazole (FLC) S. cerevisiae strains functionally hyperexpressing fungal lanosterol 14α-demethylase and resistance-conferring transporters of azole drugs. BM2 chemosensitized to FLC some FLC-resistant clinical isolates of C. albicans and C. dubliniensis and chemosensitized to itraconazole clinical isolates of C. krusei that are intrinsically resistant to FLC. The growth-inhibitory concentrations of BM2 did not cause fungal cell permeabilization, significant hemolysis of red blood cells, or the death of cultured HEp-2 epithelial cells. BM2 represents a novel class of broad-spectrum, surface-active, Pma1p-targeting fungicides which increases the potencies of azole drugs and circumvents azole resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparative Protein Structure Modeling of Genes and Genomes
Martí-Renom, M. A., Stuart, A. C., Fiser, A., Sánchez, R., Melo, F., & Šali, A. (2000) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.29.1.291 · Cited by 3,169 · cited 2×
“albicans Pma1ps with the program MODELLER (18) and a model of the homologous Neurospora crassa enzyme as the threading template (14) indicate where BM2 might bind to the Pma1ps.”
MethodClinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Research works printed but not linked: 41
- 10.1128/AAC.40.12.2835 · DOI · Paper page
- 10.1073/pnas.97.7.3254 · doi:10.1073/pnas.97.7.3254 · Paper page
- Decottignies, A., B. Rogers, M. Kowlaczkowski, E. Carvajal, E. Balzi, G. Conseil, K. Niimi, A. Di Pietro, B. C. Monk, and A. Goffeau. 2002. The pleiotropic drug ABC transporters from Saccharomyces cerevisiae, p. 157-176. In I. T. Paulsen and K. Lewis (ed.), Microbial multidrug efflux. Horizon Scientific Press, Wymondham, United Kingdom.
- 10.1128/AAC.43.1.1 · DOI · Paper page
- Eraso, P., A. Cid, and R. Serrano. 1987. Tight control of the amount of yeast plasma membrane ATPase during changes in growth conditions and gene dosage. FEBS Lett.224:193-197. · DOI
- 10.1128/AAC.47.4.1213-1219.2003 · DOI · Paper page
- 10.1128/AAC.44.12.3306-3309.2000 · doi:10.1128/aac.44.12.3306-3309.2000
- 10.1016/S0966-842X(00)01823-0 · DOI · Paper page
- 10.1073/pnas.97.16.8856 · DOI · Paper page
- 10.1016/S0167-7799(97)01156-6 · DOI · Paper page
- 10.1042/bj3260039 · DOI · Paper page
- 10.1016/S0196-9781(01)00502-2 · doi:10.1016/s0196-9781(01)00502-2
- Houghten, R. A., C. Pinilla, S. E. Blondelle, J. R. Appel, C. T. Dooley, and J. H. Cuevo. 1991. Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature354:84-86. · DOI · Paper page
- 10.1126/science.1072574 · DOI
- Kundu, B., T. Srinivasan, A. P. Kesarwani, A. Kavishwar, S. K. Raghuwanshi, S. Batra, and P. K. Shukla. 2002. Identification of novel antifungal nonapeptides through the screening of combinatorial peptide libraries based on a hexapeptide motif. Bioorg. Med. Chem. Lett.12:1473-1476. · doi:10.1016/s0960-894x(02)00174-9
- 10.1074/jbc.M300680200 · DOI · Paper page
- 10.1128/AEM.68.5.2453-2460.2002 · DOI · Paper page
- Mason, A. B., T. B. Kardos, and B. C. Monk. 1998. Regulation and pH-dependent expression of a bilaterally truncated yeast plasma membrane H+-ATPase. Biochim. Biophys. Acta1372:261-271. · doi:10.1016/s0005-2736(98)00065-0
- Mason, A. B., T. B. Kardos, D. S. Perlin, and B. C. Monk. 1996. Functional complementation between transmembrane loops of Saccharomyces cerevisiae and Candida albicans plasma membrane H+-ATPases. Biochim. Biophys. Acta1284:181-191. · doi:10.1016/s0005-2736(96)00128-9
- Mitchell, D. J., D. T. Kim, L. Steinman, C. G. Fathman, and J. B. Rothbard. 2000. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res.56:318-325. · DOI · Paper page
- Monk, B., and A. Goffeau. 2000. Platforms for antifungal discovery in the 21st century. Biochemist20:20-25.
- 10.1128/jb.173.21.6826-6836.1991 · DOI · Paper page
- Monk, B. C., A. B. Mason, G. Abramochkin, J. E. Haber, D. Seto-Young, and D. S. Perlin. 1995. The yeast plasma membrane proton pumping ATPase is a viable antifungal target. 1. Effects of the cysteine-modifying reagent omeprazole. Biochim. Biophys. Acta1239:81-90.
- Monk, B. C., C. Montesinos, C. Ferguson, K. Leonard, and R. Serrano. 1991. Immunological approaches to the transmembrane topology and conformational changes of the carboxyl terminal regulatory domain of the yeast plasma membrane H+-ATPase. J. Biol. Chem.266:18097-18103. · doi:10.1016/s0021-9258(18)55241-8
- 10.1128/jb.175.17.5566-5574.1993 · DOI
- Monk, B. C., and D. S. Perlin. 1994. Fungal plasma membrane proton pumps as promising new antifungal targets. Crit. Rev. Microbiol.20:209-233. · DOI · Paper page
- 10.1016/S0021-9258(19)50269-1 · DOI
- 10.1128/AAC.45.12.3366-3374.2001 · DOI · Paper page
- 10.1128/AAC.48.4.1256-1271.2004 · DOI · Paper page
- 10.1016/S1570-0232(02)00668-2 · DOI
- Ostresh, J. M., S. E. Blondelle, B. Dorner, and R. A. Houghten. 1996. Generation and use of nonsupport-bound peptide and peptidomimetic combinatorial libraries. Methods Enzymol.267:220-234. · doi:10.1016/s0076-6879(96)67015-3
- Pinilla, C., J. R. Appel, P. Blanc, and R. A. Houghten. 1992. Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries. BioTechniques13:901-905.
- 10.1111/j.1432-1033.1989.tb15235.x · DOI
- 10.1038/319689a0 · DOI · Paper page
- 10.1016/S0005-2736(97)00028-X · DOI
- Shi, Z., C. A. Olson, and N. R. Kallenbach. 2002. Cation-pi interaction in model alpha-helical peptides. J. Am. Chem. Soc.124:3284-3291. · DOI
- 10.1002/psc.398 · DOI · Paper page
- 10.1128/AAC.40.11.2443 · DOI · Paper page
- 10.1074/jbc.M207817200 · DOI · Paper page
- 10.1128/AAC.43.5.1267 · DOI
- 10.1124/pr.55.1.2 · DOI · Paper page
Cited by
Efflux-Mediated Antifungal Drug Resistance
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., & Monk, B. C. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-08 · Cited by 608
Self-citationCosta-de-Oliveira, S., & Rodrigues, A. G. (2020) · Microorganisms · doi:10.3390/microorganisms8020154 · Cited by 229
Identification and Rational Design of Novel Antimicrobial Peptides for Plant Protection
Marcos, J. F., Muñoz, A., Pérez-Payá, E., Misra, S., & López-García, B. (2008) · Annual Review of Phytopathology · doi:10.1146/annurev.phyto.121307.094843 · Cited by 205
Niimi, K., Maki, K., Ikeda, F., Holmes, A. R., Lamping, E., Niimi, M., Monk, B. C., & Cannon, R. D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1148-1155.2006 · Cited by 134
“We have used a Saccharomyces cerevisiae heterologous membrane protein hyperexpression system to construct a panel of mutant strains that hyperexpress individual transporter alleles cloned from fungal pathogens (19, 23, 25).”
MethodIdentification of Antifungal H + -ATPase Inhibitors with Effect on Plasma Membrane Potential
Kjellerup, L., Gordon, S., Cohrt, K. O., Brown, W. D., Fuglsang, A. T., & Winther, A.-M. L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00032-17 · Cited by 50
“Special attention should be paid to possible membrane interactions, as BM2 affects fungal membrane integrity and has previously been linked to low-level hemolysis and detectable toxicity in HEp-2 cells (10).”
BackgroundResultInfluential
Metadata
- Authors
- Monk, B. C., Niimi, K., Lin, S., Knight, A., Kardos, T. B., Cannon, R. D., Parshot, R., King, A., Lun, D., & Harding, D. R. K.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2005-01
- Volume
- 49
- Issue
- 1
- Pages
- 57-70
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2140678065
- Cited by
- 66
- References
- 2
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Surface-Active Fungicidal d -Peptide Inhibitors of the Plasma Membrane Proton Pump That Block Azole Resistance. https://app.cochat.ai/papers/10.1128/aac.49.1.57-70.2005
- The paper
- Monk, B. C., Niimi, K., Lin, S., Knight, A., Kardos, T. B., Cannon, R. D., Parshot, R., King, A., Lun, D., & Harding, D. R. K. (2005). Surface-Active Fungicidal d -Peptide Inhibitors of the Plasma Membrane Proton Pump That Block Azole Resistance. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.49.1.57-70.2005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.